188 related articles for article (PubMed ID: 18282597)
1. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
Paydas S; Ergin M; Erdogan S; Seydaoglu G
Leuk Res; 2008 Sep; 32(9):1424-30. PubMed ID: 18282597
[TBL] [Abstract][Full Text] [Related]
2. Prognostic [corrected] significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature.
Paydas S; Ergin M; Seydaoglu G; Erdogan S; Yavuz S
Leuk Res; 2009 Dec; 33(12):1627-35. PubMed ID: 19286254
[TBL] [Abstract][Full Text] [Related]
3. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
Liu JR; Lin Q; Wu XY
Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients.
Camilleri-Broët S; Camparo P; Mokhtari K; Hoang-Xuan KH; Martin A; Arborio M; Hauw JJ; Raphaël M
Mod Pathol; 2000 Feb; 13(2):158-65. PubMed ID: 10697273
[TBL] [Abstract][Full Text] [Related]
5. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
7. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma.
Sakata K; Satoh M; Someya M; Asanuma H; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Cancer; 2004 Jan; 100(2):356-65. PubMed ID: 14716772
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
Filipits M; Jaeger U; Pohl G; Stranzl T; Simonitsch I; Kaider A; Skrabs C; Pirker R
Clin Cancer Res; 2002 Mar; 8(3):729-33. PubMed ID: 11895902
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
11. [Expression of VEGF and its significance in primary diffuse large B-cell lymphoma of the female genital system].
Tang QL; Jiang XF; Yang KZ; Li HG; Liu WP; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):48-51. PubMed ID: 19292043
[TBL] [Abstract][Full Text] [Related]
12. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
[TBL] [Abstract][Full Text] [Related]
13. Correlation between EBV DNA and rearrangement and expression of Bcl-2 gene in aggressive non-Hodgkin's lymphoma.
Eissa S; Kassim SK; Imam M; Khalifa A
IUBMB Life; 1999 Aug; 48(2):231-6. PubMed ID: 10794603
[TBL] [Abstract][Full Text] [Related]
14. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
15. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in nodal B cell lymphomas: a high throughput study.
Tzankov A; Heiss S; Ebner S; Sterlacci W; Schaefer G; Augustin F; Fiegl M; Dirnhofer S
J Clin Pathol; 2007 May; 60(5):476-82. PubMed ID: 16790692
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular endothelial growth factor, basic fibroblastic growth factor, and microvessel density and their relation to cell proliferation in B-cell non-Hodgkin's lymphoma.
Alshenawy HA
Ann Diagn Pathol; 2010 Oct; 14(5):321-7. PubMed ID: 20850693
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between VEGF expression and clinical characteristic of patient with non-Hodgkin's lymphoma: an initial study].
Zhu J; Wang WY; Jiang M; Yang Y; Hou M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):418-20. PubMed ID: 18575329
[TBL] [Abstract][Full Text] [Related]
19. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression in low and high grade B-cell non-Hodgkin's lymphomas.
Ozbudak IH; Akkaya B; Karpuzoğlu G
Turk Patoloji Derg; 2011; 27(3):204-9. PubMed ID: 21935869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]